Sebastiaan Hammer

Sebastiaan Hammer

Auto-generated profile, based on publicly available information

Sebastiaan Hammer

Department of Radiology, Haga Hospital, The Hague, The Netherlands

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in JACC
Verified
Journal Article
Closed access
LRLuuk J. Rijzewijk
Luuk J. Rijzewijk
RMRutger W. van der Meer
Rutger W. van der Meer
JSJohannes W.A. Smit
Johannes W.A. Smit
MDMichaela Diamant
Michaela Diamant
JBJeroen J. Bax
Jeroen J. Bax
HLHildo J. Lamb
Hildo J. Lamb

1 September 2008 in JACC
Verified
Journal Article
Closed access
SHSebastiaan Hammer
Sebastiaan Hammer
MSMarieke Snel
Marieke Snel
HLHildo J. Lamb
Hildo J. Lamb
IJIngrid M. Jazet
Ingrid M. Jazet
RMRutger W. van der Meer
Rutger W. van der Meer
JSJohannes W.A. Smit
Johannes W.A. Smit

1 February 2007 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
ODO M Dekkers
O M Dekkers
SHS Hammer
S Hammer
RKR J W de Keizer
R J W de Keizer
FRF Roelfsema
F Roelfsema
PSP J Schutte
P J Schutte
APA.M. Pereira
A.M. Pereira
Objective: The natural history of non-functioning pituitary macroadenomas (NFMA) has not been completely elucidated. Therefore, we evaluated pituitary function, visual fields, and tumor size during long-term follow-up of non-operated patients with NFMA. Design: Follow-up study. Patients: Twenty-eight patients (age 55 ± 3 years) with NFMA, not operated after initial diagnosis, were included. Results: Initial presentation was pituitary insufficiency in 44%, visual field defects in 14%, apoplexy in 14%, and chronic headache in 7% of the patients. The duration of follow-up was 85 ± 13 months. Radiological evidence of tumor growth was observed in 14 out of 28 patients (50%) after duration of follow-up of 118 ± 24 months. Six patients (21%) were operated, because tumor growth was accompanied by visual field defects. Visual impairments improved in all the cases after transsphenoidal surgery. Spontaneous reduction in tumor volume was observed in eight patients (29%). No independent predictors for increase or decrease in tumor volume could be found by regression analysis. Conclusion: Observation alone is a safe alternative for transsphenoidal surgery in selected NFMA patients, without the risk of irreversibly compromising visual function.

1 October 2009 in Investigative Radiology
Verified
Journal Article
Closed access
SRStijntje D. Roes
Stijntje D. Roes
SHSebastiaan Hammer
Sebastiaan Hammer
RGRob J van der Geest
Rob J van der Geest
NMNina Ajmone Marsan
Nina Ajmone Marsan
JBJeroen J. Bax
Jeroen J. Bax
JWJos J. M. Westenberg
Jos J. M. Westenberg
To validate 3-dimensional (3D) 3-directional velocity-encoded (VE) magnetic resonance imaging (MRI) for flow assessment through all 4 heart valves simultaneously with retrospective valve-tracking during off-line analysis in healthy volunteers and in patients with valvular regurgitation. Three-dimensional 3-directional VE MRI was performed in 22 healthy volunteers and in 29 patients with ischemic cardiomyopathy who were suspected of valvular regurgitation and net flow volumes through the 4 heart valves were compared. Furthermore, the analysis was repeated for each valve in 10 healthy volunteers and in 10 regurgitant valves to assess intra- and interobserver agreement for assessment of respectively net flow volumes and regurgitation fraction. In healthy volunteers, the average net flow volume through the mitral valve, tricuspid valve, aortic valve, and pulmonary valve was 85 ± 20 mL, 85 ± 21 mL, 83 ± 19 mL, 82 ± 21 mL, respectively. Strong correlations between net flow volumes through the 4 heart valves were observed (intraclass correlation coefficients [ICC] 0.93–0.95) and the coefficient of variance (CV) was small (6%–9%). The repeated analysis by the same observer and by a second observer yielded good agreement for measurement of net flow volumes (ICC: 0.93–0.99 and CV: 3%–7%). Strong correlations between the net flow volumes through the 4 heart valves were also observed in the patients with valvular regurgitation (ICC: 0.85–0.95 and CV: 7%–18%). The average net flow volume through the mitral valve, tricuspid valve, aortic valve, and pulmonary valve was 63 ± 20 mL, 63 ± 20 mL, 63 ± 20 mL, 63 ± 20 mL, respectively. Furthermore, the intra- and interobserver agreement for assessment of regurgitation fraction was good (ICC: 0.86 and 0.85, CV: 12% and 13%). Flow assessment using 3D 3-directional VE MR with retrospective valve-tracking during off-line analysis enables accurate quantification of net flow volumes through 4 heart valves within a single acquisition in healthy volunteers and in patients with valvular regurgitation.

1 December 2007 in Diabetes
Verified
Journal Article
Open access
PDF file
RMRutger W. van der Meer
Rutger W. van der Meer
SHSebastiaan Hammer
Sebastiaan Hammer
JSJohannes W.A. Smit
Johannes W.A. Smit
MFMarijke FrölIch
Marijke FrölIch
JBJeroen J. Bax
Jeroen J. Bax
HLHildo J. Lamb
Hildo J. Lamb
OBJECTIVE—Diabetes and obesity are associated with increased plasma nonesterified fatty acid (NEFA) levels, myocardial triglyceride accumulation, and myocardial dysfunction. Because a very low–calorie diet (VLCD) also increases plasma NEFA levels, we studied the effect of a VLCD on myocardial triglyceride content and cardiac function in healthy subjects. RESEARCH DESIGN AND METHODS—Fourteen healthy nonobese men underwent 1H-magnetic resonance spectroscopy (MRS) to determine myocardial and hepatic triglyceride content, 31P-MRS to assess myocardial high-energy phosphate (HEP) metabolism (phosphocreatine/ATP), and magnetic resonance imaging of myocardial function at baseline and after a 3-day VLCD. RESULTS—After the dietary intervention, plasma NEFA levels increased compared with those at baseline (from 0.5 ± 0.1 to 1.1 ± 0.1 mmol/l, P < 0.05). Concomitantly, myocardial triglyceride content increased by ∼55% compared with that at baseline (from 0.38 ± 0.05 to 0.59 ± 0.06%, P < 0.05), whereas liver triglyceride content decreased by ∼32% (from 2.2 ± 0.5 to 1.5 ± 0.4%, P < 0.05). The VLCD did not change myocardial phosphocreatine-to-ATP ratio (2.33 ± 0.15 vs. 2.33 ± 0.08, P > 0.05) or systolic function. Interestingly, deceleration of the early diastolic flow across the mitral valve decreased after the VLCD (from 3.37 ± 0.20 to 2.91 ± 0.16 ml/s2 × 10−3, P < 0.05). This decrease in diastolic function was significantly correlated with the increase in myocardial triglyceride content. CONCLUSIONS—Short-term VLCD induces accumulation of myocardial triglycerides. In addition, VLCD decreases left ventricular diastolic function, without alterations in myocardial HEP metabolism. This study documents diet-dependent physiological variations in myocardial triglyceride content and diastolic function in healthy subjects.

3 January 2008 in European Heart Journal
Verified
Journal Article
Open access
PDF file
RMRutger W. van der Meer
Rutger W. van der Meer
LRLuuk J. Rijzewijk
Luuk J. Rijzewijk
MDMichaela Diamant
Michaela Diamant
SHSebastiaan Hammer
Sebastiaan Hammer
MSMichael Schär
Michael Schär
HLHildo J. Lamb
Hildo J. Lamb
In animal models of obesity and diabetes mellitus, myocardial TG accumulation is associated with decreased myocardial function. In the physiologically ageing heart, myocardial triglyceride (TG) accumulation may also occur due to reduced myocardial fatty acid oxidation. The role of myocardial TG in the ageing human heart is unknown. Therefore, the purpose of our study was to evaluate the effects of ageing on myocardial TG content, and to determine the association between myocardial TG content and heart function. 1H-magnetic resonance spectroscopy and magnetic resonance imaging of the heart were performed in 43 healthy male subjects. Mean age (range) of the subjects was 44 (20–66) years. Body mass index (BMI), blood pressure, and biochemical markers were determined. Age correlated significantly to myocardial TG content (r = 0.57, P< 0.05) independently of BMI. Furthermore, myocardial TG content correlated negatively with left ventricular diastolic function (represented by E/A ratio, r = −0.68, P < 0.05). Multivariable analysis indicated myocardial TG content as independent predictor (P < 0.05) of the age related decrease in diastolic heart function. Myocardial TG content increases in the physiologically ageing male heart and is associated with the age-related decline in diastolic function, independent of BMI, blood pressure, and biochemical blood markers.